vitro
test
commonli
use
determin
target
action
antihiv
drug
assay
measur
activ
follow
viral
enzym
revers
transcriptas
rt
polymeras
rnaseh
activ
advantag
enzymat
assay
test
tube
straightforward
perform
requir
special
safeti
infrastructur
produc
clear
interpret
result
howev
previou
indic
presum
target
new
drug
difficult
know
assay
start
case
viral
resist
select
inhibitor
target
action
need
determin
sequenc
analysi
timeconsum
cumbersom
current
mani
testtub
assay
describ
measur
distinct
interact
proteinprotein
rnaprotein
essenti
viral
replic
new
assay
howev
basi
testtub
studi
mechan
action
sever
compound
mistakenli
ascrib
inhibit
certain
target
upon
studi
cell
cultur
appear
inhibit
offsit
target
exampl
suramin
first
found
potent
inhibitor
retrovir
revers
transcript
process
test
tube
block
vitro
infect
cytopath
effect
first
antivir
drug
shown
vitro
block
hiv
infect
also
first
proven
effect
suppress
hiv
replic
hivinfect
although
suramin
origin
pursu
antihiv
potenti
rtinhibitori
capac
sinc
becom
clear
cell
cultur
suramin
primarili
target
viral
adsorpt
involv
viral
envelop
glycoprotein
ref
anoth
exampl
tat
inhibitor
ref
shown
target
viral
entri
cell
yet
anoth
exampl
lchicor
acid
deriv
counteract
integras
activ
vitro
cell
cultur
block
viru
therefor
tool
character
mechan
action
viru
inhibitor
cell
cultur
requir
defin
correct
target
sever
test
studi
target
action
antivir
compound
cell
cultur
exampl
compar
activ
compound
versu
persist
latent
infect
easili
determin
whether
inhibitor
target
pre
postintegr
step
viral
replic
drug
block
product
new
viru
persist
infect
cell
presum
target
postintegr
event
persist
infect
system
preintegr
step
viru
bind
revers
transcript
integr
omit
altern
sever
step
hiv
replic
cycl
eg
viru
viral
exist
specif
test
cell
perform
studi
effect
potenti
inhibitor
target
exampl
one
presum
newli
discov
inhibitor
interfer
viru
bind
virusbind
perform
howev
none
assay
combin
properti
one
test
cover
full
replic
cycl
compound
concentr
antivir
activ
toxic
compound
determin
toa
experi
perform
concentr
compound
use
toa
experi
establish
bromid
confirm
compound
toxic
cell
concentr
lower
concentr
use
although
recommend
use
concentr
lower
tenfold
could
result
insuffici
inhibit
viral
replic
moreov
recommend
check
solubl
compound
aqueou
medium
intend
concentr
precipit
reduc
final
concentr
compound
viru
replic
capac
cell
line
use
protocol
import
use
highli
suscept
cell
line
combin
highli
replic
viru
ensur
replic
accur
measur
h
infect
case
hiv
pretest
carri
ensur
suffici
high
viru
product
measur
h
infect
fig
virus
time
requir
one
replic
round
first
determin
order
assign
suitabl
detect
window
addit
amount
inoculum
requir
optim
ensur
suffici
viru
releas
supernat
time
harvest
control
avail
alway
includ
suffici
controlrefer
compound
well
establish
target
interact
detect
viral
replic
viru
replic
monitor
differ
way
hiv
usual
virusassoci
antigen
supernat
infect
cell
quantifi
elisa
commerci
avail
differ
supplier
method
virusassoci
rt
activ
assay
kit
avail
differ
supplier
quantit
use
altern
centrifug
multifug
heraeu
centrifug
tube
ml
tpp
cat
eppendorf
highperform
microcentrifug
eppendorf
cat
cat
fixedangl
rotor
ml
includ
aerosoltight
aluminum
lid
cup
eppendorf
safe
lock
eppendorf
cat
tissu
cultur
test
plate
tpp
cat
polystyren
roundbottom
tube
ml
bd
falcon
cat
incubatorlaminar
airflow
class
iia
clean
air
cat
safeti
laboratori
complet
contain
mm
hepe
buffer
supplement
volvol
heatinactiv
fc
mm
lglutamin
gentamicin
store
month
prepar
stock
solut
test
compoundshomogen
aliquot
test
compound
prepar
prepar
describ
earlier
refer
commonli
use
solvent
dmso
water
buffer
solut
ensur
compound
dissolv
well
solvent
use
rule
thumb
longterm
storag
compound
store
howev
storag
condit
maximum
storag
durat
depend
compound
concern
one
presum
degrad
compound
advis
compar
antivir
activ
fresh
solut
old
solut
antivir
experi
compound
solut
need
maintain
room
temperatur
protect
light
time
min
plu
h
incub
cell
suspens
add
requir
amount
viru
reach
multipl
infect
per
well
bulk
infect
see
box
viru
titrat
box
exampl
calcul
cautional
experi
use
viru
perform
appropri
safeti
laboratori
train
skill
personnel
take
requir
secur
precaut
especi
viru
stock
high
titer
use
infect
add
suspens
bulk
infect
tube
contain
compound
solut
tube
step
repres
time
point
tube
rest
bulk
infect
humidifi
atmospher
air
incub
h
incub
add
ml
complet
medium
tube
enlarg
volum
bulk
suspens
ml
complet
infect
cell
tube
bulk
infect
centrifug
min
room
temperatur
remov
supernat
resuspend
cell
ml
complet
step
twice
total
three
centrifug
final
resuspend
complet
medium
tube
cell
per
ml
bulk
infect
critic
stepappropri
wash
remov
unbound
viru
necessari
minim
wash
step
step
add
compound
solut
well
plate
use
time
point
bulk
suspens
well
time
point
h
transfer
tube
compound
solut
plate
correspond
time
point
bulk
suspens
add
remain
well
plate
use
experi
place
plate
humidifi
atmospher
air
store
compound
solut
dark
room
temperatur
time
min
time
point
interv
hour
add
compound
dilut
well
correspond
correct
time
point
place
plate
back
humidifi
atmospher
h
infect
microscop
score
plate
cytotox
visual
monitor
cell
morpholog
andor
eventu
crystallizationprecipit
compound
solut
next
take
supernat
well
inactiv
ad
triton
store
quantifi
virusassoci
core
antigen
elisapaus
pointth
sampl
may
store
month
without
affect
virusassoci
core
antigen
supernat
elisa
use
commerci
avail
kit
perkinelm
follow
manufactur
amount
pg
versu
time
point
see
fig
panel
b
troubleshoot
troubleshoot
advic
found
tabl
sampl
prepar
step
min
infect
step
min
step
incub
step
min
step
min
compound
addit
step
min
compound
interv
h
step
min
step
time
requir
perform
elisa
depend
kit
correspond
manufactur
instruct
step
min
time
start
experi
obtain
final
result
protocol
enabl
target
action
newli
discov
antivir
drug
determin
cell
cultur
exampl
rt
inhibitor
azt
abl
inhibit
replic
present
within
first
h
infect
fig
contrari
ad
h
infect
later
unabl
inhibit
viral
replic
target
action
revers
transcript
process
alreadi
occur
target
longer
import
replic
viru
singl
round
infect
point
imper
includ
control
drug
known
wellcharacter
target
action
experi
drug
unknown
target
action
show
similar
profil
establish
antihiv
agent
strongli
suggest
drug
target
process
least
target
one
oper
time
notabl
use
assay
make
possibl
discrimin
rt
inhibitor
nucleosid
rt
inhibitor
type
nrti
versu
nnrti
type
fig
inde
consist
observ
experi
nrti
ddn
analog
lose
antivir
activ
exactli
h
nnrti
like
fact
ddn
analog
need
undergo
phosphoryl
cellular
enzym
becom
activ
chain
termin
rt
reaction
one
keep
mind
drug
dual
target
action
ie
one
molecul
target
two
distinct
step
within
replic
cycl
alway
last
occur
target
viral
replic
reveal
experi
last
step
replic
block
inhibitor
illustr
point
sever
combin
two
wellknown
hiv
inhibitor
combin
one
experi
fig
case
dextran
sulfat
inhibitor
viral
entri
combin
azt
rt
inhibitor
toa
assay
reveal
revers
transcript
target
combin
azt
combin
integras
inhibitor
integras
reveal
target
special
exampl
drug
dual
mechan
action
polysulfon
dendrim
low
concentr
cell
cultur
inhibit
viral
adsorpt
ad
higher
concentr
also
target
process
coincid
viral
revers
transcript
fig
explain
extent
cellular
uptak
drug
differ
concentr
differenti
potenc
differ
process
therefor
toa
experi
advis
test
compound
differ
concentr
possibl
compound
complet
block
hiv
replic
mani
case
compound
present
low
concentr
complet
inhibit
viru
replic
low
intrins
potenc
first
case
remedi
increas
concentr
compound
cytotox
solubl
aqueou
medium
compound
limit
factor
notic
compound
abl
inhibit
viral
replic
gener
valu
replic
assay
reach
complet
block
viral
replic
lack
intrins
potenc
even
complet
inhibit
viral
replic
establish
certain
compound
satisfactori
reliabl
result
could
obtain
toa
assay
case
one
expect
see
residu
amount
time
point
occur
target
compound
zero
reach
block
viral
replic
lower
control
without
compound
also
possibl
sometim
slight
slope
loss
activ
observ
instead
clear
jump
toxic
compound
compound
target
step
viral
replic
involv
iter
process
take
place
sever
hour
mani
variat
toa
experi
envisag
eg
socal
neg
toa
experi
perform
drug
need
time
process
host
cell
becom
activ
cell
experi
compound
ad
differ
time
point
viru
infect
take
place
similar
approach
use
mechan
action
compound
base
upregul
cellular
cofactor
involv
viral
replic
addit
shorter
time
period
compound
addit
min
use
instead
interv
